Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 401Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3AUCTA

02 6ACTAVIS ELIZABETH

03 6ALEMBIC

04 9ALKEM LABS LTD

05 3AMNEAL

06 6ANNORA PHARMA

07 3AUROBINDO PHARMA

08 3AUROBINDO PHARMA LTD

09 3BIONPHARMA

10 3CHARTWELL RX

11 6CIPLA

12 3GLENMARK SPECLT

13 3JUBILANT GENERICS

14 9MSN

15 6NORVIUM BIOSCIENCE

16 6NOVARTIS

17 3NOVARTIS PHARMS CORP

18 3PHARMOBEDIENT

19 3PIRAMAL

20 3STEVENS J

21 6SUN PHARM

22 9TEVA PHARMS USA

23 3TORRENT

24 6ZYDUS PHARMS

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

RLD : No

TE Code : AB

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : GRANULE;ORAL

Dosage Strength : 90MG

Approval Date : 2021-03-09

Application Number : 214559

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Aucta Company Banner

02

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

RLD : No

TE Code : AB

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : GRANULE;ORAL

Dosage Strength : 180MG

Approval Date : 2021-03-09

Application Number : 214559

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Aucta Company Banner

03

  • fda
  • EDQM
  • WHO-GMP

Virtual BoothAucta is a global brand that creates better products from proven molecules.

RLD : No

TE Code : AB

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : GRANULE;ORAL

Dosage Strength : 360MG

Approval Date : 2021-03-09

Application Number : 214559

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

Aucta Company Banner

04

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 125MG

Approval Date : 2016-01-26

Application Number : 203560

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

05

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 250MG

Approval Date : 2016-01-26

Application Number : 203560

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

06

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 500MG

Approval Date : 2016-01-26

Application Number : 203560

RX/OTC/DISCN : RX

RLD : No

TE Code : AB

blank

07

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 125MG

Approval Date : 2005-11-02

Application Number : 21882

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

08

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 250MG

Approval Date : 2005-11-02

Application Number : 21882

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

09

The MedTech Conference
Not Confirmed
arrow
arrow
The MedTech Conference
Not Confirmed

DEFERASIROX

Brand Name : EXJADE

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 500MG

Approval Date : 2005-11-02

Application Number : 21882

RX/OTC/DISCN : RX

RLD : Yes

TE Code : AB

blank

10

PHARMOBEDIENT

Country
The MedTech Conference
Not Confirmed
arrow

PHARMOBEDIENT

Country
arrow
The MedTech Conference
Not Confirmed

DEFERASIROX

Brand Name : DEFERASIROX

Dosage Form : TABLET, FOR SUSPENSION;ORAL

Dosage Strength : 125MG

Approval Date : 2024-05-17

Application Number : 206585

RX/OTC/DISCN : DISCN

RLD : No

TE Code :

blank